Mofezolac
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
[3,4-bis(4-methoxyphenyl)isoxazol-5-yl]acetic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 78967-07-4 Y |
ATC code | none |
PubChem | CID 4237 |
ChemSpider | 4089 |
UNII | RVJ0BV3H3Y Y |
KEGG | D01718 Y |
Chemical data | |
Formula | C19H17NO5 |
Molar mass | 339.34 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Mofezolac (INN) is a non-steroidal anti-inflammatory drug.
References[edit]
Pyrazolones / Pyrazolidines |
|
---|---|
Salicylates | |
Acetic acid derivatives and related substances |
|
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) |
|
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications.
|
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mofezolac&oldid=713218519"